NCT05332873View on ClinicalTrials.gov

Rivet PVS Therapy in Group 2 PH-HFpEF Canada

NAWithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 31, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2025

Conditions

Heart FailurePulmonary Hypertension

Interventions

DEVICE

Rivet Shunt

The Rivet Shunt device will be implanted via a percutaneous, transcatheter approach

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NXT Biomedical

INDUSTRY